(19)
(11) EP 4 798 625 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24805043.7

(22) Date of filing: 25.10.2024
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
C12N 15/113(2010.01)
C12N 5/0783(2010.01)
C12N 15/85(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2824; C07K 2317/81; C12N 15/1138; C12N 2310/20; C12N 5/0636; C07K 2317/622; C12N 2740/10043; C12N 15/90
(86) International application number:
PCT/US2024/053136
(87) International publication number:
WO 2025/090978 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 26.10.2023 US 202363545828 P

(71) Applicant: CARGO Therapeutics, Inc.
San Carlos, California 94070 (US)

(72) Inventors:
  • YI, Michael
    San Carlos, California 94070 (US)
  • QUACH, Boi
    San Carlos, California 94070 (US)
  • BETHUNE, Michael
    San Carlos, California 94070 (US)
  • SIEGEL, Matthew
    San Carlos, California 94070 (US)
  • NGUYEN, Nhung
    San Carlos, California 94070 (US)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) MODIFIED IMMUNE EFFECTOR CELLS